Thymosin Alpha-1 15mg — Vial Spec, Reconstitution Math & COA

Overview of Thymosin Alpha-1 15mg Mass and Laboratory Utility

Thymosin Alpha-1 (TA1) is an acidic 28-amino-acid peptide (molecular weight approximately 3,108.3 Da) naturally derived from thymosin fraction 5. In laboratory settings, the synthetic 15mg lyophilized vial serves as a bulk-scale research format, engineered specifically for high-frequency or multi-plate assay workflows where lower vial yields (such as 2mg or 5mg) would require frequent reconstitution events and introduce lot-to-lot baseline variability across longitudinal trials.

Principal investigators utilizing the 15mg format typically conduct cell-culture signaling assays, high-density flow cytometry analysis, or extended preclinical animal model studies. Securing a higher mass per single vial minimizes inter-vial reconstitution discrepancies, standardizes stock solution concentrations across large experiment arrays, and optimizes storage space within standard freezer infrastructure. All preparations must remain strictly within controlled laboratory environments.

Catalog Availability, Fill Sizes, and Order Selection

PX1 Research maintains rigorous inventory standards for all synthetic peptides, prioritizing physical purity and chemical stability over arbitrary mass options. Depending on current production cycles and lot allocations, PX1 Research may offer specific unit masses to match demand while ensuring fresh, non-degraded product. When evaluating your experimental design, it is critical to select a vial size that aligns with your planned assay timeline to avoid unnecessary freeze-thaw degradation.

If a specific 15mg presentation is temporarily out of stock or unlisted, research laboratories routinely utilize our standard Thymosin Alpha-1 5mg format in multiples to achieve identical overall mass yields without compromising sequence integrity. You can inspect all available unit sizes and complementary compounds across our broader catalog at all peptides. For high-volume research institutions planning multi-gram evaluations, specialized custom sizing can be coordinated directly via our wholesale portal.

Biochemical Structure and Preclinical Research Mechanisms

Preclinical studies suggest that Thymosin Alpha-1 exerts distinct modulatory influence over innate and adaptive immune signaling cascades in cellular models. Structurally, the N-terminal acetylated sequence (Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH) interacts with specific pattern recognition receptors, including Toll-like receptor 4 (TLR4) and Toll-like receptor 7 (TLR7), triggering downstream nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) pathways.

In vitro data indicate that exposure to Thymosin Alpha-1 modulates the expression of major histocompatibility complex (MHC) Class I molecules, enhances interleukin-2 (IL-2) and interferon-gamma (IFN-γ) secretion in primary lymphocyte cultures, and alters natural killer (NK) cell cytotoxic activity. Because these physiological actions depend strictly on conformational stability, maintaining accurate solution molarity during lab handling is essential for consistent receptor binding dynamics.

Volumetric Reconstitution Math for 15mg Vials

Reconstituting a 15mg lyophilized cake requires precise solvent addition to hit desired stock concentrations (mg/mL or µg/µL) without exceeding compound solubility limits. Researchers commonly employ Bacteriostatic Water (0.9% benzyl alcohol) for multi-use working stocks intended for short-term refrigeration, or Sterile Water for Injection / Phosphate-Buffered Saline (PBS) when conducting immediate, sensitive cell culture assays where preservatives could interfere with cellular viability.

Below are the volumetric concentration calculations for a 15mg Thymosin Alpha-1 vial based on standard diluent volumes: • 1.0 mL Diluent Addition: 15 mg / 1.0 mL = 15.0 mg/mL (15.0 µg/µL) • 2.0 mL Diluent Addition: 15 mg / 2.0 mL = 7.5 mg/mL (7.5 µg/µL) • 3.0 mL Diluent Addition: 15 mg / 3.0 mL = 5.0 mg/mL (5.0 µg/µL) • 5.0 mL Diluent Addition: 15 mg / 5.0 mL = 3.0 mg/mL (3.0 µg/µL)

When performing precision micro-aliquoting, researchers should utilize our interactive reconstitution calculator to compute precise micro-liter delivery volumes for specific target micromolar (µM) concentrations in culture media.

Aliquot Planning, Dilution Protocols, and Thermal Storage

Lyophilized Thymosin Alpha-1 15mg powder exhibits robust long-term stability when stored in desiccated conditions at -20°C to -80°C, protected from light exposure. Upon liquid reconstitution, repeated freeze-thaw cycles must be strictly avoided, as thermal cycling causes peptide cleavage, aggregation, and loss of biological activity.

To maximize stability, laboratories should establish an aliquot workflow immediately after reconstitution: 1. Allow the sealed lyophilized vial to equilibrate to room temperature before adding solvent to prevent condensation contamination. 2. Gently introduce the chosen diluent down the glass vial wall; do not vortex vigorously. Solubilize via gentle swirling. 3. Aspirate the stock solution using sterile, low-binding pipette tips. 4. Dispense single-use aliquots (e.g., 50 µL to 200 µL) into sterile polypropylene microcentrifuge tubes. 5. Flash-freeze aliquots in liquid nitrogen or dry ice, then transfer to a manual defrost freezer at -80°C for long-term storage.

Reconstituted stocks maintained at 2°C to 8°C in bacteriostatic diluent should generally be consumed within 14 to 28 days to prevent gradual peptide hydrolysis.

Comparative Analysis: Thymosin Alpha-1 and Related Regulatory Peptides

When designing preclinical immune-modulatory or tissue-recovery models, principal investigators frequently compare Thymosin Alpha-1 against other endogenous regulator compounds. While Thymosin Alpha-1 specifically targets T-cell differentiation and TLR-mediated pathways, Thymosin Beta-4 operates primarily via actin-sequestering mechanisms to influence cell migration and tissue remodeling. Similarly, the host-defense peptide LL-37 demonstrates direct antimicrobial membrane disruption and distinct inflammatory signaling, whereas BPC-157 exhibits cytoprotective and angiogenic pathways in non-immune cell lineages. Selecting the appropriate research compound depends heavily on whether the targeted assay focuses on broad-spectrum immune cell expression or localized extracellular matrix response.

Analytical Quality Assurance: Lot-Matched HPLC, MS, and COA Verification

Every batch of Thymosin Alpha-1 distributed by PX1 Research undergoes rigorous third-party testing in ISO 17025 accredited analytical laboratories located within the United States. High-Performance Liquid Chromatography (HPLC) is conducted to verify chemical purity, ensuring that every lot exceeds our baseline requirement of 98.0% purity. Mass Spectrometry (MS) confirms exact molecular weight identity, verifying correct amino acid sequencing without truncated fragment impurities.

Furthermore, because bacterial endotoxins can confound cellular signaling assays and invalidate preclinical models, PX1 Research performs quantitative Chromogenic LAL Endotoxin Testing on every production lot. Researchers can independently inspect, download, and verify batch-specific test results at any time via our centralized COA verification directory. All peptides are manufactured in GMP-compliant facilities to enforce strict lot-to-lot consistency.

Bulk Handling, Laboratory Workflows, and High-Yield Ordering

High-yield formats like the 15mg presentation are engineered to lower per-milligram research costs and streamline high-volume experimental runs. When conducting multi-plate screening, maintaining single-batch uniform stock prevents micro-variations that could otherwise skew standard curves or duplicate assays.

PX1 Research ships all orders rapidly from domestic logistics facilities situated in California and Arizona. Orders received Monday through Friday are processed with same-day dispatch, ensuring minimal transit delays and maintaining temperature integrity. Institutional accounts requiring specialized bulk quantities, custom vial packaging, or dedicated batch reservations can coordinate through our wholesale services hub for tailored support.

Solvent Compatibility and In Vitro Handling Considerations

Depending on the experimental model, choosing the correct solvent system is vital. For cell culture assays targeting membrane dynamics or cytokine release, organic solvents or preserved waters may induce cellular toxicity. In such instances, sterile 0.9% normal saline or non-preserved Phosphate-Buffered Saline (PBS, pH 7.4) is recommended for immediate application.

If solubilizing in neutral buffers proves challenging at maximum concentrations (e.g., above 10 mg/mL), a tiny drop of dilute acetic acid (0.1%) can assist in fully disaggregating the acidic peptide chain, followed by immediate neutralization with culture medium. Always verify solubility parameters prior to adding primary cell cultures or sensitive cell lines.

Summary Specification and Storage Protocol Checklist

To ensure maximal compound integrity throughout your research, follow this protocol summary: • Physical Mass: 15mg lyophilized cake (or equivalent aggregated units). • Sequence Purity: ≥98.0% as determined by HPLC. • Identity: Verified by Mass Spectrometry (3108.3 Da ± 1 Da). • Storage (Lyophilized): Keep sealed at -20°C for up to 24 months. • Storage (Reconstituted): Store single-use aliquots at -80°C; avoid repeated freeze-thaw cycles. • Logistics: USA-manufactured, shipped same-day M–F from CA/AZ centers.

For additional scientific documentation or mechanism overviews, explore our complete research library.